154 related articles for article (PubMed ID: 30262141)
61. Utilizing the peptidyl-prolyl cis-trans isomerase pin1 as a probe of its phosphorylated target proteins. Examples of binding to nuclear proteins in a human kidney cell line and to tau in Alzheimer's diseased brain.
Thorpe JR; Morley SJ; Rulten SL
J Histochem Cytochem; 2001 Jan; 49(1):97-108. PubMed ID: 11118482
[TBL] [Abstract][Full Text] [Related]
62. The role of Pin1 in the development and treatment of cancer.
Min SH; Zhou XZ; Lu KP
Arch Pharm Res; 2016 Dec; 39(12):1609-1620. PubMed ID: 27572155
[TBL] [Abstract][Full Text] [Related]
63. The structure of the Candida albicans Ess1 prolyl isomerase reveals a well-ordered linker that restricts domain mobility.
Li Z; Li H; Devasahayam G; Gemmill T; Chaturvedi V; Hanes SD; Van Roey P
Biochemistry; 2005 Apr; 44(16):6180-9. PubMed ID: 15835905
[TBL] [Abstract][Full Text] [Related]
64. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production.
Pastorino L; Sun A; Lu PJ; Zhou XZ; Balastik M; Finn G; Wulf G; Lim J; Li SH; Li X; Xia W; Nicholson LK; Lu KP
Nature; 2006 Mar; 440(7083):528-34. PubMed ID: 16554819
[TBL] [Abstract][Full Text] [Related]
65. Gears-In-Motion: The Interplay of WW and PPIase Domains in Pin1.
Lee YM; Liou YC
Front Oncol; 2018; 8():469. PubMed ID: 30460195
[TBL] [Abstract][Full Text] [Related]
66. Cysteine-mediated dynamic hydrogen-bonding network in the active site of Pin1.
Barman A; Hamelberg D
Biochemistry; 2014 Jun; 53(23):3839-50. PubMed ID: 24840168
[TBL] [Abstract][Full Text] [Related]
67. Identification and characterization of a novel and functional murine Pin1 isoform.
Zhu JX; Dagostino E; Rejto PA; Mroczkowski B; Murray B
Biochem Biophys Res Commun; 2007 Aug; 359(3):529-35. PubMed ID: 17548053
[TBL] [Abstract][Full Text] [Related]
68. Peptidyl-Prolyl cis/trans Isomerase NIMA-Interacting 1 as a Therapeutic Target in Hepatocellular Carcinoma.
Kim G; Kim JY; Choi HS
Biol Pharm Bull; 2015; 38(7):975-9. PubMed ID: 26133706
[TBL] [Abstract][Full Text] [Related]
69. [Pin1: a multi-talented peptidyl prolyl cis-trans isomerase and a promising therapeutic target for human cancers].
Marsolier J; Weitzman JB
Med Sci (Paris); 2014; 30(8-9):772-8. PubMed ID: 25174754
[TBL] [Abstract][Full Text] [Related]
70. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response.
Zheng H; You H; Zhou XZ; Murray SA; Uchida T; Wulf G; Gu L; Tang X; Lu KP; Xiao ZX
Nature; 2002 Oct; 419(6909):849-53. PubMed ID: 12397361
[TBL] [Abstract][Full Text] [Related]
71. Rhein exhibits antitumorigenic effects by interfering with the interaction between prolyl isomerase Pin1 and c-Jun.
Cho JH; Chae JI; Shim JH
Oncol Rep; 2017 Mar; 37(3):1865-1872. PubMed ID: 28184937
[TBL] [Abstract][Full Text] [Related]
72. Structure and function of the human parvulins Pin1 and Par14/17.
Matena A; Rehic E; Hönig D; Kamba B; Bayer P
Biol Chem; 2018 Jan; 399(2):101-125. PubMed ID: 29040060
[TBL] [Abstract][Full Text] [Related]
73. Conformational selection in the recognition of phosphorylated substrates by the catalytic domain of human Pin1.
Velazquez HA; Hamelberg D
Biochemistry; 2011 Nov; 50(44):9605-15. PubMed ID: 21967280
[TBL] [Abstract][Full Text] [Related]
74. The peptidyl-prolyl isomerase Pin1 regulates cytokinesis through Cep55.
van der Horst A; Khanna KK
Cancer Res; 2009 Aug; 69(16):6651-9. PubMed ID: 19638580
[TBL] [Abstract][Full Text] [Related]
75. Preparation of protein transduction domain-fused peptidyl prolyl cis/trans isomerase Pin1.
Ohashi T; Teshima S; Hidaka M; Uchida T
Biosci Biotechnol Biochem; 2010; 74(10):2067-70. PubMed ID: 20944414
[TBL] [Abstract][Full Text] [Related]
76. Destabilization of KLF10, a tumor suppressor, relies on thr93 phosphorylation and isomerase association.
Hwang YC; Yang CH; Lin CH; Ch'ang HJ; Chang VHS; Yu WCY
Biochim Biophys Acta; 2013 Dec; 1833(12):3035-3045. PubMed ID: 23994618
[TBL] [Abstract][Full Text] [Related]
77. COT phosphorylates prolyl-isomerase Pin1 to promote tumorigenesis in breast cancer.
Kim G; Khanal P; Kim JY; Yun HJ; Lim SC; Shim JH; Choi HS
Mol Carcinog; 2015 Jun; 54(6):440-8. PubMed ID: 24265246
[TBL] [Abstract][Full Text] [Related]
78. 1H, 13C and 15N backbone resonance assignment of the peptidyl-prolyl cis-trans isomerase Pin1.
Jacobs DM; Saxena K; Grimme S; Vogtherr M; Pescatore B; Langer T; Elshorst B; Fiebig KM
J Biomol NMR; 2002 Jun; 23(2):163-4. PubMed ID: 12153046
[No Abstract] [Full Text] [Related]
79. Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1.
Urusova DV; Shim JH; Kim DJ; Jung SK; Zykova TA; Carper A; Bode AM; Dong Z
Cancer Prev Res (Phila); 2011 Sep; 4(9):1366-77. PubMed ID: 21750208
[TBL] [Abstract][Full Text] [Related]
80. Targeting Peptidyl-prolyl Cis-trans Isomerase NIMA-interacting 1: A Structure-based Virtual Screening Approach to Find Novel Inhibitors.
da Costa KS; Galúcio JM; de Jesus DA; Gomes GC; Lima E Lima AH; Taube PS; Dos Santos AM; Lameira J
Curr Comput Aided Drug Des; 2020; 16(5):605-617. PubMed ID: 31654518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
